floxacillin has been researched along with meropenem in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 5 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Giebaly, DE; Horriat, S; Mangaleshkar, S; Sinha, A | 1 |
| Bowler, IC; Buchanan, R; Crook, D; Stoesser, N | 1 |
| Brenner, T; Hoppe-Tichy, T; Pinder, N; Swoboda, S; Weigand, MA | 1 |
| Buscher, H; Gentili, S; Imani, S; Marriott, D; Sandaradura, I | 1 |
| Dorn, C; Hitzenbichler, F; Kees, F; Kees, MG; Kratzer, A; Lubnow, M; Salzberger, B; Schießer, S | 1 |
| Doogue, M; Jensen, BP; Mortensen, JS | 1 |
| Bahmany, S; Barzel, I; Hunfeld, NGM; Jessurun, JG; Koch, BCP; van der Kuy, PHM | 1 |
| de Grauw, AM; Kruizinga, MD; Leegwater, E; Storm, BN; van Veen, M; Wewerinke, L | 1 |
| Abdulla, A; Bahmany, S; Ewoldt, TMJ; Koch, BCP | 1 |
1 review(s) available for floxacillin and meropenem
| Article | Year |
|---|---|
Preanalytical Stability of Flucloxacillin, Piperacillin, Tazobactam, Meropenem, Cefalexin, Cefazolin, and Ceftazidime in Therapeutic Drug Monitoring: A Structured Review.
Topics: Anti-Bacterial Agents; Cefazolin; Ceftazidime; Cephalexin; Drug Monitoring; Drug Stability; Floxacillin; Humans; Meropenem; Piperacillin; Tazobactam | 2022 |
12 other study(ies) available for floxacillin and meropenem
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Pyomyositis of the piriformis muscle presenting with sciatica in a teenage rugby player.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Floxacillin; Football; Humans; Low Back Pain; Magnetic Resonance Imaging; Male; Meropenem; Pain; Piriformis Muscle Syndrome; Pyomyositis; Rifampin; Sciatica; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vancomycin | 2012 |
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
Therapeutic drug monitoring of beta-lactam antibiotics - Influence of sample stability on the analysis of piperacillin, meropenem, ceftazidime and flucloxacillin by HPLC-UV.
Topics: Anti-Bacterial Agents; Ceftazidime; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Floxacillin; Meropenem; Piperacillin; Thienamycins | 2017 |
Too much of a good thing: a retrospective study of β-lactam concentration-toxicity relationships.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clostridium Infections; Cohort Studies; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Floxacillin; Humans; Incidence; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurotoxicity Syndromes; Piperacillin; Retrospective Studies; Thienamycins | 2017 |
Measurement of Free Plasma Concentrations of Beta-Lactam Antibiotics: An Applicability Study in Intensive Care Unit Patients.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Floxacillin; Humans; Intensive Care Units; Meropenem; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Staphylococcus aureus | 2021 |
Evaluation of the importance of mixing during preparation of antibiotic infusions.
Topics: Anti-Bacterial Agents; Cefuroxime; Floxacillin; Infusions, Intravenous; Meropenem; Vancomycin | 2022 |
Optimization of β-Lactam Dosing Regimens in Neonatal Infections: Continuous and Extended Administration versus Intermittent Administration.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Communicable Diseases; Floxacillin; Humans; Infant, Newborn; Infusions, Intravenous; Meropenem; Microbial Sensitivity Tests; Monobactams; Monte Carlo Method | 2023 |
Stability of 10 Beta-Lactam Antibiotics in Human Plasma at Different Storage Conditions.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Ceftriaxone; Cefuroxime; Floxacillin; Humans; Imipenem; Meropenem; Monobactams; Piperacillin; Tandem Mass Spectrometry | 2023 |